Literature DB >> 33637436

Statin nonadherence in Latino and noncitizen neighborhoods in New York City, Los Angeles, and Chicago, 2012-2016.

Jenny S Guadamuz, Ramon A Durazo-Arvizu, Martha L Daviglus, Gregory S Calip, Edith A Nutescu, Dima M Qato.   

Abstract

BACKGROUND: Latino adults, especially immigrants without citizenship (i.e., noncitizens), experience considerable barriers to health care, including medications. Inequitable access to medications, especially statins, may exacerbate disparities in cardiovascular disease. Despite this, little is known about medication nonadherence in Latino neighborhoods, especially those with large noncitizen populations.
OBJECTIVES: To estimate nonadherence to statins in Latino neighborhoods and evaluate differences on the basis of their noncitizen population.
METHODS: We conducted a retrospective cohort study among 48,161 adults who lived in predominately Latino neighborhoods in New York City, Los Angeles, and Chicago and who initiated statin therapy from January 2012 to December 2015 using IQVIA LifeLink. Statin nonadherence was defined as a proportion of days covered amounting to less than 80% over 12 months. We focused on differences between neighborhoods with high noncitizen concentrations (areas where noncitizens are at least 35% of the adult population) and other Latino neighborhoods. We examined associations using logistic regressions adjusted for individual (e.g., payment method) and neighborhood characteristics (e.g., poverty).
RESULTS: Individuals living in neighborhoods with high noncitizen concentrations were more nonadherent to statins than those in Latino neighborhoods with fewer noncitizens (75.0% vs. 70.0%, adjusted odds ratio [aOR] 1.18, [95% CI 1.06-1.33]). These disparities were worse in New York City (77.7% vs. 69.1%, aOR 1.37, [95% CI 1.23-1.53]) and Chicago (76.1% vs. 68.8%, aOR 1.38, [95% CI 1.14-1.67]) than in Los Angeles (73.8% vs. 71.3%, aOR 1.10, [95% CI 1.01-1.20]).
CONCLUSION: Neighborhoods with large noncitizen populations have much higher rates of statin nonadherence than Latino neighborhoods with fewer noncitizens. These disparities were least pronounced in Los Angeles, where the county provides health care to all uninsured residents, including noncitizens without documentation to reside in the United States. Efforts to improve medication access in Latino neighborhoods should be multifocal and start by implementing state and local health care options for low-income residents, regardless of citizenship status.
Copyright © 2021 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33637436      PMCID: PMC8273086          DOI: 10.1016/j.japh.2021.01.032

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  14 in total

1.  'Pharmacy deserts' are prevalent in Chicago's predominantly minority communities, raising medication access concerns.

Authors:  Dima M Qato; Martha L Daviglus; Jocelyn Wilder; Todd Lee; Danya Qato; Bruce Lambert
Journal:  Health Aff (Millwood)       Date:  2014-11       Impact factor: 6.301

2.  Consequences of Recent Anti-immigration Policy.

Authors:  Paul Dourgnon; Partha Das
Journal:  JAMA Intern Med       Date:  2017-10-01       Impact factor: 21.873

3.  Access-To-Care Differences Between Mexican-Heritage And Other Latinos In California After The Affordable Care Act.

Authors:  Arturo Vargas Bustamante; Ryan M McKenna; Joseph Viana; Alexander N Ortega; Jie Chen
Journal:  Health Aff (Millwood)       Date:  2018-09       Impact factor: 6.301

4.  Residential segregation and disparities in health care services utilization.

Authors:  Darrell J Gaskin; Gniesha Y Dinwiddie; Kitty S Chan; Rachael McCleary
Journal:  Med Care Res Rev       Date:  2011-10-04       Impact factor: 3.929

Review 5.  Polypharmacy: Evaluating Risks and Deprescribing.

Authors:  Anne D Halli-Tierney; Catherine Scarbrough; Dana Carroll
Journal:  Am Fam Physician       Date:  2019-07-01       Impact factor: 3.292

6.  Immigration Status and Disparities in the Treatment of Cardiovascular Disease Risk Factors in the Hispanic Community Health Study/Study of Latinos (Visit 2, 2014-2017).

Authors:  Jenny S Guadamuz; Ramon A Durazo-Arvizu; Martha L Daviglus; Krista M Perreira; Gregory S Calip; Edith A Nutescu; Linda C Gallo; Sheila F Castaneda; Franklyn Gonzalez; Dima M Qato
Journal:  Am J Public Health       Date:  2020-07-16       Impact factor: 9.308

7.  Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.

Authors:  Sudeep Karve; Mario A Cleves; Mark Helm; Teresa J Hudson; Donna S West; Bradley C Martin
Journal:  Curr Med Res Opin       Date:  2009-09       Impact factor: 2.580

8.  Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.

Authors:  Fatima Rodriguez; David J Maron; Joshua W Knowles; Salim S Virani; Shoutzu Lin; Paul A Heidenreich
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

9.  Variations in healthcare access and utilization among Mexican immigrants: the role of documentation status.

Authors:  Arturo Vargas Bustamante; Hai Fang; Jeremiah Garza; Olivia Carter-Pokras; Steven P Wallace; John A Rizzo; Alexander N Ortega
Journal:  J Immigr Minor Health       Date:  2012-02

10.  Association Between Pharmacy Closures and Adherence to Cardiovascular Medications Among Older US Adults.

Authors:  Dima M Qato; G Caleb Alexander; Apurba Chakraborty; Jenny S Guadamuz; John W Jackson
Journal:  JAMA Netw Open       Date:  2019-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.